SCHEMBL4395052

SCHEMBL4395052

Cc1c(C(=O)NC2(C(=O)O)CC2)cc(C(C)(C)C)c(O)c1C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PYGL P06737 7/20 0.37
CXCR5 P32302 3/20 0.36
GLRA3 O75311 1/20 0.36
GLRB P48167 1/20 0.36
MCL1 Q07820 1/20 0.34
CNR2 P34972 2/20 0.34
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP2C9 P11712 1/20 0.33
ERAP1 Q9NZ08 1/20 0.33
CA2 P00918 1/20 0.33
POLB P06746 1/20 0.33
TYR P14679 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR5A2 O00482 1/20 0.32
NR5A1 Q13285 1/20 0.32
CNR1 P21554 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4394175 0.78 LMNA (0.42) GLRA3GLRBALDH1A1GAATDP1
SCHEMBL30893094 0.76 GLRA3 (0.52) GLRA3GLRBALDH1A1GAATDP1
SCHEMBL5000262 0.76 GLRA3 (0.52) GLRA3GLRBALDH1A1GAATDP1
SCHEMBL11631722 0.74 NR5A2 (0.46) GLRA3GLRBALDH1A1GAATDP1
SCHEMBL4391183 0.72 MAOB (0.40) GLRA3GLRBCNR2ALDH1A1GAA
SCHEMBL8605774 0.71 GAA (0.35) GLRA3GLRBALDH1A1GAATDP1
SCHEMBL8605885 0.71 NR5A2 (0.46) GLRA3GLRBALDH1A1GAATDP1
SCHEMBL29477956 0.70 SMN1; SMN2 (0.41) GLRA3GLRBALDH1A1GAATDP1
Potassium Ion SCHEMBL29477999 0.70 SMN1; SMN2 (0.41) GLRA3GLRBALDH1A1GAATDP1
SCHEMBL8605769 0.69 NR5A2 (0.50) GAACA2NR5A2NR5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009132453-A1 CYCLYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS NEUROMED PHARMACEUTICALS LTD. (CA) 2009-11-05 WO disclosed